S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

NCT00006237 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

432

Enrollment

NETWORK

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: interleukin-2
BIOLOGICAL: filgrastim
BIOLOGICAL: interferon alfa
DRUG: cisplatin
DRUG: dacarbazine
DRUG: vinblastine

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]